In a lab somewhere, a chemist is trying to make a molecule without blowing anything up. The traditional path involves immense heat and pressure, a centralized, energy-hungry process that is both a carbon liability and a single point of failure. Rhoic, a quiet startup out of the Bay Area, is betting that a box full of electrified nanofibers can offer a safer, distributed alternative [Biofuels Digest, 2025].
Its core technology is the Maxwell Reactor, a device that uses a volumetric matrix of electrospun, conductive nanofibers coated with catalyst nanoparticles [Biofuels Digest, 2025]. Apply a high-frequency AC field, and the fiber tips become nanoscale field emitters. The resulting electric field gradients polarize target molecules right at the catalyst surface, theoretically lowering the energy needed to snap specific chemical bonds into place [Biofuels Digest, 2025]. The promise is selective chemistry without the furnace.
A wedge into defense and pharma
Rhoic is not aiming for commodity chemicals. Its initial targets are defense-critical energetics and pharmaceutical precursors, two areas where supply chain fragility or geopolitical risk makes decentralized, efficient production strategically valuable [Biofuels Digest, 2025]. It is a classic climate-tech wedge: enter through a premium, regulated application where performance and security outweigh pure cost, then drive down the learning curve. Founder Ashley Bernstein, previously of climate investment firm Cordillera Climate Solutions, brings a lens tuned to both the technical and commercial hurdles of deep tech [ZoomInfo]. The company’s $200,000 pre-seed round drew support from a mix of climate-focused investors and hard-tech accelerators, including Sandy Spring Climate Partners, mHUB, and Activate Global [PitchBook, 2026].
The unit economics of a field gradient
The bet rests on translating a laboratory effect into a reliable, scalable piece of industrial hardware. The potential energy savings are the obvious climate hook, but the real economic driver for early customers would be the ability to manufacture sensitive compounds on-site, reducing transport risk and complexity. For a pharmaceutical company synthesizing a novel precursor, or a defense contractor producing a specialized propellant, the value of a compact, controllable reactor could justify a significant price tag.
A back-of-the-envelope calculation illustrates the scale of the challenge. A standard industrial batch reactor for high-value chemical synthesis can cost from $500,000 to several million dollars. For Rhoic’s technology to be compelling, its Maxwell Reactor must not only match the output and purity of those incumbents but do so with substantially lower operating costs (energy) and capital footprint (size). If it can achieve a 30% reduction in energy use while fitting in a standard lab bay, the unit economics for a niche customer start to pencil out.
Where the molecules must align
This is exceptionally hard hardware. The risks are not abstract.
- Materials science. The durability and consistency of the catalytic nanofiber mats under continuous electrical and chemical stress are unproven at scale. Catalyst fouling or fiber degradation could tank throughput.
- Process intensity. Pharmaceutical manufacturing, in particular, is governed by strict Good Manufacturing Practice (GMP) regulations. Proving that a field-induced reaction can be validated and controlled to meet those standards is a multi-year, capital-intensive journey.
- The incumbent moat. Rhoic is not just competing against other reactors; it is competing against entire entrenched chemical engineering paradigms and the vast sunk cost of existing infrastructure. For many chemicals, the thermal pathway is brutally efficient precisely because it has been optimized for a century.
The company’s current hiring push for a founding electrical/mechanical engineer in Emeryville suggests it is in the build-and-test phase, moving from slide deck to prototype [Wellfound]. The investor lineup, heavy on national lab connections (Lawrence Berkeley) and hardware accelerators, is the right kind of support for this grind [Activate Global].
The next twelve months
Visibility is low, as it is for any pre-seed hardware company still assembling its core team. The milestones to watch will be technical: a peer-reviewed paper demonstrating the core reaction efficacy, a partnership with a national lab for testing, or a design win with a research arm in its target industries. Revenue is likely years away. For now, Rhoic must prove its nanofibers can reliably do, in a repeatable box, what its slides say they can do in a microscope.
Ultimately, Rhoic’s bet is that the Maxwell Reactor can become the preferred method for synthesizing high-value, tricky molecules in regulated industries. To win, it must beat not a startup, but the entire industrial chemistry playbook,the sprawling, energy-intensive plants operated by companies like BASF or Pfizer. It is a small box aiming at a very large wall.
Sources
- [Biofuels Digest, 2025] The Digest’s 2025 Multi-Slide Guide to Rhoic and nanofiber manufacturing | https://www.biofuelsdigest.com/bdigest/the-digests-2025-multi-slide-guide-to-rhoic-and-nanofiber-manufacturing/
- [ZoomInfo] Contact Ashley Bernstein, Email: a***@rhoic.co & Phone Number | Co-founder & Chief Operating Officer | https://www.zoominfo.com/p/Ashley-Bernstein/1791760774
- [PitchBook, 2026] Rhoic 2026 Company Profile: Valuation, Funding & Investors | https://pitchbook.com/profiles/company/707618-80
- [Wellfound] Founding Engineer (EE/ME) at Rhoic • Emeryville | https://wellfound.com/jobs/3281944-founding-engineer-ee-me
- [Activate Global] Fellowship program for hard-tech entrepreneurs | https://www.activate.org